What is JFL Life Sciences Ltd. Quarterly Revenue?

JFL Life Sciences Ltd. Quarterly Revenue JFL Life Sciences Jun-2026 Quarterly Revenue is Rs 11 Cr which is growth of -4.0% YoY.

What is JFL Life Sciences Ltd. Quarterly Net Profit?

JFL Life Sciences Ltd. Quarterly Net Profit JFL Life Sciences Jun-2026 Quarterly Net Profit is Rs 1 Cr which is growth of 49.2% YoY.

What is JFL Life Sciences Ltd. Annual Revenue?

JFL Life Sciences Ltd. Annual Revenue JFL Life Sciences Mar-2026 Annual Revenue is Rs 131 Cr which is growth of 60.2% YoY.

What is JFL Life Sciences Ltd. Annual Net Profit?

JFL Life Sciences Ltd. Annual Net Profit JFL Life Sciences Mar-2026 Annual Net Profit is Rs 6 Cr which is growth of 54.0% YoY.

What is JFL Life Sciences Ltd. Total Shareholders Fund?

JFL Life Sciences Ltd. Total Shareholders Fund JFL Life Sciences Mar-2026 Total Shareholders Fund is Rs 46 Cr which is growth of 16.3% YoY.

What is JFL Life Sciences Ltd. Total Assets?

JFL Life Sciences Ltd. Total Assets JFL Life Sciences Mar-2026 Total Assets is Rs 106 Cr which is growth of 47.7% YoY.

What is JFL Life Sciences Ltd. Book Value Per Share?

JFL Life Sciences Ltd. Book Value Per Share JFL Life Sciences Mar-2026 Book Value Per Share is 14 Rs which is growth of 16.3% YoY.

What is JFL Life Sciences Ltd. ROE?

JFL Life Sciences Ltd. ROE JFL Life Sciences Mar-2026 ROE is 14% which is growth of 3.4% YoY.

What is JFL Life Sciences Ltd. Cash From Operating Activity?

JFL Life Sciences Ltd. Cash From Operating Activity JFL Life Sciences Mar-2026 Cash From Operating Activity is Rs -4 Cr which is growth of -22.6% YoY.

What is JFL Life Sciences Ltd. Net Cash Flow?

JFL Life Sciences Ltd. Net Cash Flow JFL Life Sciences Mar-2026 Net Cash Flow is Rs 1 Cr which is growth of 414650.0% YoY.

JFL Life Sciences Ltd.

NSE: JFLLIFE

Strong Performer, Under Radar

Download real time

-0.10(-0.98%)

34.09% Fall from 52W High

6,000

NSE Volume

NSE 06 Oct, 2026 11:33 AM (IST)

Portfolio

Alert

My Notes

JFL Life Sciences quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

JFL Life Sciences quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

NEGATIVE
Quarterly Revenue JFL Life Sciences Jun-2026 Quarterly Revenue is Rs 11 Cr which is growth of -4.0% YoY.
POSITIVE
Quarterly Net Profit JFL Life Sciences Jun-2026 Quarterly Net Profit is Rs 1 Cr which is growth of 49.2% YoY.

JFL Life Sciences Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
Indicator	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23
TOTAL_SR_Q Total Rev. ⌄	11.1	63.1	26.9	29.9	11.6	11.7	21.3	39.5	9.6	20	6
SR_Q Operating Rev.	11.1	63.1	26.8	29.9	11.6	11.7	21.3	39.5	9.5	20.3	5.6
OI_Q Other Income	0	0	0	0			0			-0.3	0.4
OEXPNS_Q Operating Exp.	9	59.5	23.5	27	9.7	10.4	19.9	37.1	6.5	18.1	5.2
OEXPNS_Q Operating Exp.	9	59.5	23.5	27	9.7	10.4	19.9	37.1	6.5	18.1	5.2
OP_Q Operating Profit	2.1	3.5	3.4	2.9	1.9	1.4	1.3	2.4	3.1	2.1	0.4
OPMPCT_Q Operating Profit Margin %	18.85%	5.58%	12.47%	9.75%	16.69%	11.72%	6.32%	6.09%	32.03%	10.54%	7.40%
DEP_Q Depr.	0.3	0.3	0.3	0.3	0.3	0.4	0.2	0.2	0.2	0.1	0.1
INT_Q Interest	0.3	1	0.4	0.4	0.2	0.3	0.2	0.3	0.3	0.1	0.4
PBT_Q Profit Before Tax	1.5	2.3	2.7	2.2	1.4	0.7	1	1.9	2.6	1.7	0.3
TAX_Q Tax	0.4	0.6	0.7	0.2	0.7	0.6	0.3	0.5	0.6	-0	0
NP_Q Net Profit	1.1	1.7	2	2	0.8	0.1	0.7	1.4	1.9	1.7	0.3
EPS_adj_Q EPS Adj. latest	0.2	0.3	0.3	0.3	0.1	0	0.1	0.2	0.3	0.3	0
NP_TTM Net profit TTM	6.8	6.4	4.8	3.6	3	4.2	5.8	5.3	-	-	-
EPS_TTM Basic EPS TTM	1.9	1.9	1.3	1.3	1.3	3.8	1	3	3	3	2.6
earnings_transcripts Earnings Transcripts

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

JFL Life Sciences competitor comparison and performance snapshot within industry

JFL Life Sciences annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue JFL Life Sciences Mar-2026 Annual Revenue is Rs 131 Cr which is growth of 60.2% YoY.
POSITIVE
Annual Net Profit JFL Life Sciences Mar-2026 Annual Net Profit is Rs 6 Cr which is growth of 54.0% YoY.

JFL Life Sciences Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19
SR_A Total Rev. Ann. ⌄	43.5%	31.9%	131	131.5	82.1	47.1	44.5	34.5	32.9	30.2	31.8
TotalOperatingRevenues_A Operating Rev. Ann.	45.3%	32%	130.9	131.4	82	46.6	42.8	33.6	32.8	30.2	31.8
OI_A Other Income Ann.	-60.3%	0%	0.1	0.1	0	0.5	1.6	0.9	0.1	0
OEXPNS_A Operating Exp. Ann.	45.5%	31.4%	119	119.7	73.8	42	38.9	28.2	30.6	28.3	30.5
OEXPNS_A Operating Exp. Ann.	45.5%	31.4%	119	119.7	73.8	42	38.9	28.2	30.6	28.3	30.5
OP_A Operating Profit Ann.	44.2%	39.7%	11.9	11.7	8.2	4.5	3.9	5.4	2.2	1.9	1.3
OPMPCT_A OPM Ann. %	0.3%	6.3%		8.91%	9.99%	9.66%	8.84%	15.55%	6.58%	6.17%	4.16%
TotalExpenses_A Total Exp. Ann. ⌄	44.4%	30.8%		122.9	75.9	43.3	40.8	30.7	32.1	29.7	31.4
OtherExpenses_A Other Exp. Ann.	14.5%	38.8%	3.8	3.6	6.7	1.1	2.4	1	0.7	0.6	0.4
EmployeeBenefitExpenses_A Employee Exp. Ann.	-15.1%	1.9%	1.2	1.1	1	2	1.8	1.4	1	1.3	1
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	28.2%	38.7%		11.8	8.2	5.1	5.6	6.3	2.3	1.9	1.3
EBIDTPCT_A EBITDA Ann. margin %	-10.6%	5.5%		8.96%	10.00%	10.77%	12.53%	18.13%	6.86%	6.28%	4.16%
INT_A Interest Ann.	14.5%	11.8%	2.2	2.1	1.1	0.8	1.4	2.1	1.2	1.2	0.8
DEP_A Depr.	40.1%	29.7%	1.1	1.1	1	0.4	0.4	0.4	0.3	0.2	0.2
PBT_A PBT Ann.	32.5%	60.8%	8.7	8.6	6.1	3.8	3.7	3.8	0.8	0.5	0.4
TAX_A Tax Ann.	34.7%	61.5%	1.9	2.2	2	0.5	0.9	1	0.2	0.1	0.1
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	31.7%	66.5%		6.4	4.2	3.3	2.8	2.8	0.5	0.4	0.3
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-		-	-	-	-	-	-	-	-
NP_A Net Profit Ann.	31.7%	66.5%	6.8	6.4	4.2	3.3	2.8	2.8	0.5	0.4	0.3
NETPCT_A NPM Ann. %	-9.5%	24.2%		4.87%	5.06%	7.10%	6.56%	8.36%	1.65%	1.19%	0.95%
EPS_adj_A EPS Adj. latest Ann.	35.7%	58.5%		1	0.6	0.5	0.4	0.4	0.1	0.1	0.1

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

60.2%

2Y CAGR

67.1%

3Y CAGR

43.5%

5Y CAGR

31.9%

7Y CAGR

22.5%

Total Revenue Annual growth is higher than historical averages.

Net Profit Ann.

1Y CHG

52.4%

2Y CAGR

39.3%

3Y CAGR

31.7%

5Y CAGR

66.5%

7Y CAGR

54.8%

Net Profit Annual growth is stable compared to historical averages.

Operating Exp. Ann.

1Y CHG

62.2%

2Y CAGR

68.8%

3Y CAGR

45.5%

5Y CAGR

31.4%

7Y CAGR

21.6%

Operating Expenses Annual Cr growth is higher than historical averages.

JFL Life Sciences balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund JFL Life Sciences Mar-2026 Total Shareholders Fund is Rs 46 Cr which is growth of 16.3% YoY.
POSITIVE
Total Assets JFL Life Sciences Mar-2026 Total Assets is Rs 106 Cr which is growth of 47.7% YoY.

JFL Life Sciences Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	12.4%	46.1%	45.9	39.5	35.6	32.3	11.3	6.9	5.4	5
EQCAP_A Equity Share Capital Ann.	44.2%	131.2%	33	33	11	11	8	0.5	0.4	0.4
TotalShareCapital_A Total Share Capital Ann.	44.2%	131.2%	33	33	11	11	8	0.5	0.4	0.4
ReservesAndSurplus_A Reserves Plus Surplus Ann.	-15.4%	15%	12.9	6.5	24.6	21.3	3.3	6.4	5	4.6
TotalReservesAndSurplus_A Total Reserves Plus Surplus Ann.	-15.4%	15%	12.9	6.5	24.6	21.3	3.3	6.4	5	4.6
LiabilityMinorityInterest_A Minority Interest Liability Ann.	-	-	-	-	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann. ⌄	66.6%	-2.5%	7.4	0.8	1.1	1.6	8.6	8.4	1.5	3
DeferredTaxLiabilities_A Deferred Tax Liabilities Ann.	26%	32%	0.4	0.3		0.2	0.2	0.1	0.1	0.1
OtherLongTermLiabilities_A Other LongTerm Liabilities Ann.	-	-
CL_A Total Current Liabilities Ann. ⌄	51.6%	30.9%	53	31.6	20	15.2	28.4	13.8	17.5	8.1
TradePayables_A Trade Payables Ann.	58.2%	44.8%	29.3	17.8	9.8	7.4	15.4	4.6	8.8	1.4
OtherCurrentLiabilities_A Other Current Liabilities Ann.	101.7%	83%	8.2	3.6	3.8	1	4.4	0.4	0.5	1.1
ShortTermProvisions_A ST Provisions Ann.	-14%	28.5%	0.7	0.1	1.7	1.1	1.2	0.2	0.1	0.1
TL_A Total Capital Plus Liabilities Ann.	29.4%	29.7%	106.3	71.9	56.6	49.1	48.3	29	24.3	16.2
FixedAssets_A Fixed Assets Ann. ⌄	28.7%	17.4%	14.5	12.2	12.5	6.8	7.1	6.5	5.1	2.5
TangibleAssets_A Tangible Assets Ann.	28.7%	17.4%	14.5	12.2	12.5	6.8	7.1	6.5	5.1	2.5
IntangibleAssets_A Intangible Assets Ann.	-	-
CapitalWorkInProgress_A Capital Work In Progress Ann.	-	-								0
TotalNonCurrentAssets_A Total Non Current Assets Ann. ⌄	23.3%	11.5%	14.8	12.4	13.5	7.9	9	8.6	6	2.6
NonCurrentInvestments_A Non Current Investments Ann.	-	-
DeferredTaxAssets_A Deferred Tax Assets Ann.	-	-			0.1
LongTermLoansAndAdvances_A LT Loans Plus Advances Ann.	-	-			0.5	0.7	0.8	0.1	0.1	0
OtherNonCurrentAssets_A Other Non Current Assets Ann.	-20.6%	-36.3%	0.2	0.2	0.4	0.4	1	1.9	0.8
CA_A Total Current Assets Ann. ⌄	30.6%	34.9%	91.5	59.5	43.1	41.1	39.3	20.5	18.4	13.6
CurrentInvestments_A Current Investments Ann.	-	-
TradeReceivables_A Trade Receivables Ann.	33.3%	35.2%	53.3	35	25.2	22.5	19.8	11.8	12.7	9.7
CashAndCashEquivalents_A Cash Plus Cash Equivalents Ann.	146.6%	-	1.5	0.1	0	0.1	0.2	0	0.3	0
ShortTermLoansAndAdvances_A ST Loans Plus Advances Ann.	-	-			2.1	5.8	4.3	2.9	1.7	2.2
OtherCurrentAssets_A Other Current Assets Ann.	180.2%	-	2.2	1.3	0	0.1	0.1
TA_A Total Assets Ann.	29.4%	29.7%	106.3	71.9	56.6	49.1	48.3	29	24.3	16.2
ContingentLiabilities_A Contingent Liabilities plus Commitments Ann.	-	-	1.3	1.3
BonusEquityShareCapital_A Bonus Equity Share Capital Ann.	58.4%	-	29.4	29.4	7.4	7.4	7.4
NonCurrentInvestmentsUnquotedBookValue_A Non Current Investments Unquoted Book Value Ann.	-	-
CurrentInvestmentsUnquotedBookValue_A Current Investments Unquoted Book Value Ann.	-	-

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Assets Ann.

1Y CHG

47.8%

2Y CAGR

37%

3Y CAGR

29.4%

5Y CAGR

29.7%

7Y CAGR

30.8%

Total Assets Annual growth is higher than historical averages.

Total Current Liabilities Ann.

1Y CHG

67.7%

2Y CAGR

62.8%

3Y CAGR

51.6%

5Y CAGR

30.9%

7Y CAGR

30.8%

Total Current Liabilities Annual Cr growth is higher than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

16.2%

2Y CAGR

13.5%

3Y CAGR

12.4%

5Y CAGR

46.1%

7Y CAGR

37.3%

Total ShareHolders Funds Annual growth is stable compared to historical averages.

JFL Life Sciences ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Book Value Per Share JFL Life Sciences Mar-2026 Book Value Per Share is 14 Rs which is growth of 16.3% YoY.
POSITIVE
ROE JFL Life Sciences Mar-2026 ROE is 14% which is growth of 3.4% YoY.

JFL Life Sciences Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19
BVSH_A BVSH Ann.	-22%	-36.8%	13.9	12	32.3	29.3	14.1	138.3	127.1	118.6
ROA_A RoA Ann. %	1.7%	26.5%	6.02%	5.78%	5.84%	5.72%	5.82%	1.86%	1.48%	1.87%
ROE_A ROE Ann. %	17%	12.1%	13.95%	10.53%	9.29%	8.70%	24.88%	7.88%	6.70%	6.03%
ROCE_A ROCE Ann. %	9.8%	9.1%	20.10%	17.91%	12.61%	15.18%	29.57%	12.99%	24.30%	14.57%
ProfitabilityHeader Profitability Ratio ⌄
PBDITMargin_A EBITDA Ann. Margin %	-11.7%	5.4%	8.96%	10.00%	10.88%	13.00%	18.60%	6.88%	6.28%	4.16%
PBITMargin_A EBIT Ann. Margin %	-12.1%	6.1%	8.14%	8.79%	9.93%	12.00%	17.50%	6.04%	5.49%	3.67%
PBTMargin_A PBT Ann. Margin %	-9%	23.6%	6.54%	7.47%	8.16%	8.68%	11.31%	2.27%	1.64%	1.33%
NETPCT_A NPM Ann. %	-9.5%	24.2%	4.87%	5.06%	7.10%	6.56%	8.36%	1.65%	1.19%	0.95%
ASETTO_A Asset Turnover Ann. %	18.6%	4.6%	1.5	1.3	0.9	0.9	0.9	1.2	1.5	-
LiquidityHeader Liquidity Ratio ⌄
CRATIO_A Current Ratio Ann.	-14.3%	2.5%	1.7	1.9	2.2	2.7	1.4	1.5	1.1	1.7
QuickRatio_A Quick Ratio Ann.	-16.7%	0%	1.1	1.2	1.4	1.9	0.9	1.1	0.8	1.5
DividendPayoutNP_A Dividend Payout to NP Ann.	-	-			-	-	-	-	-	-
EarningRetention_A Earning Retention Ann. %	-	-
CashEarningRetention_A Cash Earning Retention Ann. %	-	-
CashEarningRetention_A Cash Earning Retention Ann. %	-	-
ValuationHeader Valuation Ratio ⌄
EnterpriseValue_A EnterpriseValue Ann.	3.8%	-	48.5	68.1	48.9	43.4
EVPerNetSales_A EV Per Net Sales Ann.	-26.3%	-	0.4	0.8	1.1	1	-	-	-	-
PBV_A Price To Book Value Adjusted	34.4%	64.8%	0.85	0.94	0.94	0.35	0.72	0.07	0.08	0.09
EVPerEBITDA_A EV Per EBITDA Ann.	-19.3%	-	4.1	8.3	9.7	7.8	-	-	-	-
MarketCapPerSales_A Market Cap Per Sales Ann.	-39.4%	-	0.2	0.7	0.9	0.9	-	-	-	-
RetentionRatios_A Retention Ratio Ann. %	-	-
EYield_A Earnings Yield Ann.	26%	-	0.2	0.1	0.1	0.1
DEBT_CE_A Total Debt to Total Equity Ann.	35.7%	-27.5%	0.5	0.3	0.2	0.2	1.4	2.5	1.7	1.7

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

ROE Ann. %

1Y CHG

32.5%

2Y CAGR

22.5%

3Y CAGR

17%

5Y CAGR

12.1%

7Y CAGR

12.7%

ROE Annual % is growing faster than historical averages.

RoA Ann. %

1Y CHG

4.2%

2Y CAGR

1.5%

3Y CAGR

1.7%

5Y CAGR

26.5%

7Y CAGR

18.2%

RoA Annual % is stable compared to historical averages.

Current Ratio Ann.

1Y CHG

-10.5%

2Y CAGR

-12.1%

3Y CAGR

-14.3%

5Y CAGR

2.5%

Current Ratio Annual is falling faster than historical averages.

JFL Life Sciences cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Cash From Operating Activity JFL Life Sciences Mar-2026 Cash From Operating Activity is Rs -4 Cr which is growth of -22.6% YoY.
POSITIVE
Net Cash Flow JFL Life Sciences Mar-2026 Net Cash Flow is Rs 1 Cr which is growth of 414650.0% YoY.

JFL Life Sciences Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19
CFO_A Cash from Operating Act. Ann. ⌄	-	-	-4.3	-3.5	8.4	-9.1	2.3	-5.9	3.2	-3
PBT_A PBT Ann.	32.5%	60.8%	8.6	6.1	3.8	3.7	3.8	0.8	0.5	0.4
INT_A Interest Ann.	14.5%	11.8%	2.1	1.1	0.8	1.4	2.1	1.2	1.2	0.8
TAX_A Tax Ann.	34.7%	61.5%	2.2	2	0.5	0.9	1	0.2	0.1	0.1
CFI_A Cash from Investing Act. Ann.	-	-	-3.9	-0	-6.1	0.9	-0.7	-1.6	-2.8	-0.6
CFA_A Cash from Financing Act. Ann.	4%	4.5%	9.1	3.5	-2.3	8.1	-1.5	7.3	-0.2	3.6
NCF_A Net Cash Flow Ann. ⌄	-	-	0.8		-0	-0.1	0.2	-0.3	0.3
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	-	-	0	0	0.1	0.2	0	0.3	0	0
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	108%	-	0.9	0	0	0.1	0.2	0	0.3	0

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Cash from Financing Act. Ann.

1Y CHG

160%

3Y CAGR

5Y CAGR

4.5%

7Y CAGR

14.2%

Cash from Financing Annual Activity growth is higher than historical averages.

JFL Life Sciences investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Quarterly
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow
Documents

34.09% Fall from 52W High

JFL Life Sciences quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents